BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11091269)

  • 1. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.
    Peakman M; Stevens EJ; Lohmann T; Narendran P; Dromey J; Alexander A; Tomlinson AJ; Trucco M; Gorga JC; Chicz RM
    J Clin Invest; 1999 Nov; 104(10):1449-57. PubMed ID: 10562307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.
    Hoppu S; Härkönen T; Ronkainen MS; Simell S; Hekkala A; Toivonen A; Ilonen J; Simell O; Knip M
    Clin Exp Immunol; 2006 Apr; 144(1):59-66. PubMed ID: 16542366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase.
    Seissler J; Wohlrab U; Wuensche C; Scherbaum WA; Boehm BO
    Clin Exp Immunol; 2001 Aug; 125(2):216-21. PubMed ID: 11529912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells.
    Xie H; Deng YJ; Notkins AL; Lan MS
    Clin Exp Immunol; 1998 Sep; 113(3):367-72. PubMed ID: 9737664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dissection of an immunodominant epitope in K
    Talucci I; Arlt FA; Kreissner KO; Nasouti M; Wiessler AL; Miske R; Mindorf S; Dettmann I; Moniri M; Bayer M; Broegger Christensen P; Ayzenberg I; Kraft A; Endres M; Komorowski L; Villmann C; Doppler K; Prüss H; Maric HM
    Front Immunol; 2024; 15():1329013. PubMed ID: 38665908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
    Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
    Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new autoantigen reactive with prediabetic nonobese diabetic mice sera.
    Kang Y; Choi KS; Kim KH; Kim KS; Choi SE; Ko IY; Kim HM; Yoon JW
    Mol Cells; 1999 Aug; 9(4):358-64. PubMed ID: 10515598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera.
    Nozawa K; Fritzler MJ; von Mühlen CA; Chan EK
    Arthritis Res Ther; 2004; 6(2):R95-102. PubMed ID: 15059272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA.
    Tiberti C; D'Onofrio L; Panimolle F; Zampetti S; Maddaloni E; Buzzetti R
    Front Endocrinol (Lausanne); 2022; 13():921886. PubMed ID: 35813648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.
    Elvers KT; Geoghegan I; Shoemark DK; Lampasona V; Bingley PJ; Williams AJ
    Diabetes; 2013 Jan; 62(1):214-22. PubMed ID: 22966073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes.
    Farilla L; Tiberti C; Luzzago A; Yu L; Eisenbarth GS; Cortese R; Dotta F; Di Mario U
    Eur J Immunol; 2002 May; 32(5):1420-7. PubMed ID: 11981830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD; Atkinson MA; Notkins AL
    Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
    [No Abstract]   [Full Text] [Related]  

  • 13. IA-2 and IA-2beta: the immune response in IDDM.
    Notkins AL; Lan MS; Leslie RD
    Diabetes Metab Rev; 1998 Mar; 14(1):85-93. PubMed ID: 9605631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2.
    Seissler J; Schott M; Morgenthaler NG; Scherbaum WA
    Clin Exp Immunol; 2000 Nov; 122(2):157-63. PubMed ID: 11091269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen.
    Kolm-Litty V; Berlo S; Bonifacio E; Bearzatto M; Engel AM; Christie M; Ziegler AG; Wild T; Endl J
    J Immunol; 2000 Oct; 165(8):4676-84. PubMed ID: 11035111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.